Zhe Jiang Dayang Biotech Group Management
Management criteria checks 3/4
Zhe Jiang Dayang Biotech Group's CEO is Xujun Chen, appointed in Dec 2021, has a tenure of 3.92 years. directly owns 1.14% of the company’s shares, worth CN¥30.90M. The average tenure of the management team and the board of directors is 3.9 years and 3.9 years respectively.
Key information
Xujun Chen
Chief executive officer
CN¥554.2k
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 3.9yrs |
| CEO ownership | 1.1% |
| Management average tenure | 3.9yrs |
| Board average tenure | 3.9yrs |
CEO
Xujun Chen (47 yo)
Ms. Xujun Chen is Financial Director of Zhejiang Dayang Biotech Group Co., Ltd. (formerly known as Zhe Jiang Dayang Biotech Group Co., Ltd. (formerly known as Zhejiang Dayang Chemical Co., Ltd.)) from Dece...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| GM, Financial Director & Director | 3.9yrs | CN¥554.20k | 1.14% CN¥ 30.9m | |
| Executive Deputy GM & Vice Chairman | 3.9yrs | CN¥579.80k | 4.86% CN¥ 131.4m | |
| Deputy GM & Director | no data | CN¥505.30k | 1.69% CN¥ 45.7m | |
| Deputy GM & Director | no data | CN¥545.50k | no data | |
| R&D Center Director & Director | no data | CN¥414.80k | 0.90% CN¥ 24.4m | |
| Board Secretary | 3.9yrs | CN¥456.20k | 1.18% CN¥ 32.0m | |
| Deputy General Manager | 3.9yrs | CN¥588.10k | 0.037% CN¥ 991.2k | |
| Accounting Supervisor | no data | no data | no data | |
| Deputy General Manager | 1.6yrs | no data | no data | |
| Chairman of the Supervisory Board & Deputy Director of Human Resources Department | no data | no data | no data |
Experienced Management: 003017's management team is considered experienced (3.9 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| GM, Financial Director & Director | less than a year | CN¥554.20k | 1.14% CN¥ 30.9m | |
| Executive Deputy GM & Vice Chairman | 3.9yrs | CN¥579.80k | 4.86% CN¥ 131.4m | |
| Deputy GM & Director | 3.9yrs | CN¥505.30k | 1.69% CN¥ 45.7m | |
| Deputy GM & Director | 3.9yrs | CN¥545.50k | no data | |
| R&D Center Director & Director | 2.3yrs | CN¥414.80k | 0.90% CN¥ 24.4m | |
| Chairman of the Supervisory Board & Deputy Director of Human Resources Department | less than a year | no data | no data | |
| Chairman of the Board | 3.9yrs | CN¥683.00k | 12.76% CN¥ 345.3m | |
| Independent Director | 3.9yrs | CN¥80.00k | no data | |
| Independent Director | 3.9yrs | CN¥80.00k | no data | |
| Independent Director | 3.9yrs | CN¥80.00k | no data | |
| Shareholder Supervisor | less than a year | no data | no data |
Experienced Board: 003017's board of directors are considered experienced (3.9 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/12 04:22 |
| End of Day Share Price | 2025/11/12 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Zhe Jiang Dayang Biotech Group Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.